Myclobutanil
Myclobutanil is a fungicide of the azole class. It is used in agriculture to control fungi that threaten various crops. Myclobutanil is a sterol demethylation inhibitor, meaning it interferes with the cell membrane synthesis in fungi, effectively stopping their growth.
History
Myclobutanil was first registered for use in the United States in 1988. It was developed by Dow AgroSciences, a subsidiary of Dow Chemical Company. Since then, it has been registered for use in many countries around the world.
Uses
Myclobutanil is used to control a wide range of fungi that cause diseases in crops. It is particularly effective against powdery mildew, rust, and scab. Crops that are commonly treated with myclobutanil include grapes, apples, peaches, and strawberries.
Mode of Action
Myclobutanil works by inhibiting the biosynthesis of ergosterol, a critical component of fungal cell membranes. This disruption prevents the fungi from growing and reproducing.
Safety and Environmental Impact
Myclobutanil is considered to have low toxicity to humans and animals. However, it is not without potential risks. It has been found to be an endocrine disruptor, and there is evidence that it can cause developmental and reproductive problems in animals.
In the environment, myclobutanil is moderately persistent, with a half-life in soil of 14 to 60 days. It has low mobility in soil, which means it is unlikely to contaminate groundwater. However, it is toxic to aquatic organisms and non-target insects.
Regulatory Status
In the United States, myclobutanil is classified as a Restricted Use Pesticide (RUP) by the Environmental Protection Agency (EPA). This means it can only be sold to and used by certified applicators.
In the European Union, myclobutanil was approved for use as a fungicide in 2009. However, in 2019, the approval was not renewed due to concerns about its potential endocrine disrupting properties.
See Also
This pesticide-related article is a stub. You can help WikiMD by expanding it.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD